Cargando…

EFFECT OF COVID-19 ON PRESENTATION, MANAGEMENT AND SURVIVAL OF ST ELEVATION MYOCARDIAL INFARCTION (STEMI) PATIENTS IN A SINGLE UK CENTRE

Detalles Bibliográficos
Autores principales:	Perera, Sachintha, Rathore, Sudhir, Achan, Vinod
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Cardiology Foundation. Published by Elsevier Inc. 2021
Materias:	Spotlight on Special Topics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091280/ https://www.ncbi.nlm.nih.gov/pubmed/33994057 http://dx.doi.org/10.1016/S0735-1097(21)04434-X

Ejemplares similares

ACUTE ST ELEVATION MYOCARDIAL INFARCTION (STEMI) MANAGEMENT DURING COVID-19 ERA: AN INDIAN SURVEY REPORT BY 1083 CARDIOLOGISTS
por: Ponde, Chandrashekar, et al.
Publicado: (2021)

IMPACT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON SHORT-TERM OUTCOME IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION DURING COVID-19 PANDEMIC: INSIGHTS FROM THE INTERNATIONAL MULTICENTER ISACS-STEMI REGISTRY
por: De Luca, Giuseppe, et al.
Publicado: (2022)

PRESENTATION DELAY AMONG PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION OUTSIDE OF A COVID-19 HOT ZONE
por: McNamara, David, et al.
Publicado: (2021)

CLINICAL PROFILE AND EARLY IN-HOSPITAL OUTCOMES OF COVID-19 PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION: THE PHILIPPINE HEART CENTER EXPERIENCE
por: Denila, Rachel Ann, et al.
Publicado: (2022)

INITIAL SINGLE CENTER ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION EXPERIENCE IN NEW YORK BEFORE AND DURING THE COVID-19 PANDEMIC
por: Medranda, Giorgio, et al.
Publicado: (2021)

SUSTAINED IMPACT OF THE COVID-19 PANDEMIC ON PRESENTATIONS WITH ST-SEGMENTELEVATION MYOCARDIAL INFARCTION
por: Kassis, Nicholas, et al.
Publicado: (2022)

STEMI PRESENTATIONS IN YOUNG MALES AFTER MRNA VACCINE
por: Mandava, Sri, et al.
Publicado: (2022)

AGE-RELATED EFFECTS OF COVID-19 PANDEMIC ON MECHANICAL REPERFUSION AND 30-DAY MORTALITY FOR STEMI: RESULTS OF THE ISACS-STEMI COVID-19 REGISTRY
por: Verdoia, Monica, et al.
Publicado: (2022)

ANALYSIS OF MYOCARDIAL INFARCTION AND MYOCARDIAL INFARCTION COMPLICATIONS BEFORE AND DURING COVID-19 PANDEMIC FROM MULTIPLE HOSPITALS
por: To, Magnus, et al.
Publicado: (2022)

IMPACT OF RENIN-ANGIOTENSIN SYSTEM INHIBITORS ON MORTALITY DURING THE COVID PANDEMIC AMONG DIABETIC PATIENTS WITH STEMI UNDERGOING MECHANICAL REPERFUSION: INSIGHT FROM AN INTERNATIONAL STEMI REGISTRY
por: De Luca, Giuseppe, et al.
Publicado: (2022)

THE EFFECT OF A TISSUE PLASMINOGEN ACTIVATOR ON MYOCARDIAL INFARCTION THAT ARE POSITIVE FOR COVID-19
por: Annie, Frank H., et al.
Publicado: (2021)

TROPONIN ELEVATION AS A MANIFESTATION OF COVID-19 MYOCARDIAL INFLAMMATION ASSOCIATED WITH INCREASED MORTALITY
por: Limaye, Sneha, et al.
Publicado: (2022)

ARRHYTHMIA AND MYOCARDIAL INFARCTION INCIDENCE IN 904 PATIENTS DIAGNOSED WITH NOVEL CORONAVIRUS AT AN ACADEMIC CENTER
por: Aboyme, Andrew, et al.
Publicado: (2021)

COVID-19 COMPLICATED BY RESPIRATORY FAILURE INCREASES INPATIENT STEMI MORTALITY: MACHINE LEARNING-AUGMENTED MODIFIED PROPENSITY SCORE ADJUSTED LONGITUDINAL COHORT STUDY
por: Ynalvez, Leslie Ammabel, et al.
Publicado: (2023)

ROLE OF TELEMEDICINE NETWORK PROVIDED BY PHARMACIES TO DETECT ACUTE MYOCARDIAL INFARCTION IN PATIENTS WITH CHEST PAIN DURING CORONAVIRUS PANDEMIA
por: Nodari, Savina, et al.
Publicado: (2021)

TREATMENT OF MECHANICAL COMPLICATIONS OF ACUTE MYOCARDIAL INFARCTION DURING THE COVID-19 ERA: A COMPARISON WITH THE PRE-COVID-19 PERIOD
por: Spadaccio, Cristiano, et al.
Publicado: (2022)

COVID-19 PANDEMIC IS ASSOCIATED WITH REDUCED ADMISSIONS FOR STEMI, INCREASED ISCHAEMIA TIME, MORTALITY REMAINS THE SAME: DATA FROM A LOW COVID-19 MORBIDITY COUNTRY
por: Budrys, Povilas, et al.
Publicado: (2021)

MYOCARDIAL INVOLVEMENT IN COVID-19 - DATA FROM 102 CLINICAL AND FORENSIC AUTOPSIES IN ST PETERSBURG DURING THE FIRST WAVE OF SARS-COV2 PANDEMICS
por: Platonov, Pyotr G., et al.
Publicado: (2021)

Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction
por: Konijnenberg, Lara S F, et al.
Publicado: (2020)

CLINICAL IMPACT AND PREDICTORS OF TROPONIN ELEVATION IN PATIENTS WITH COVID-19
por: Case, Brian, et al.
Publicado: (2021)

MYOCARDIAL INJURY IN AFRICAN AMERICAN PATIENTS WITH COVID-19
por: Ganta, Nitheesha, et al.
Publicado: (2021)

RISK PREDICTORS FOR MYOCARDIAL INJURY IN SEVERE COVID-19
por: Nascimento, Jorge H.P., et al.
Publicado: (2021)

PREVALENCE AND CHARACTERISTICS OF MYOCARDIAL INJURY DURING COVID-19 PANDEMIC
por: Maino, Alessandro, et al.
Publicado: (2021)

CLINICAL OUTCOMES AND PREDICTORS OF COVID-19 PATIENTS WITH TROPONIN ELEVATION AND CONCOMITANT RENAL DYSFUNCTION
por: Case, Brian, et al.
Publicado: (2021)

COVID-19 OUTCOMES AND CLINICAL CORRELATION WITH MYOCARDIAL INJURY ON ADMISSION TO HOSPITAL
por: Manmathan, Gavin, et al.
Publicado: (2021)

EFFECTS OF ELEVATED TROPONIN ON MORTALITY IN HOSPITALIZED COVID-19 PATIENTS WITH AND WITHOUT CORONARY ARTERY DISEASE
por: Zhao, Yi, et al.
Publicado: (2022)

ELEVATED BLOOD VISCOSITY PREDICTS A HIGHER MORTALITY AMONG HOSPITALIZED PATIENTS WITH COVID-19
por: Choi, Daein, et al.
Publicado: (2022)

IN-HOSPITAL MORTALITY AND OUTCOMES IN HOSPITALIZED PATIENTS WITH MYOCARDIAL INJURY AND COVID-19 INFECTION
por: Odeh, Khalil, et al.
Publicado: (2021)

COMPUTED ALGORITHMS TO IDENTIFY SUBTYPES OF ACUTE MYOCARDIAL INJURY IN ACUTE COVID-19
por: Satterfield, Benjamin, et al.
Publicado: (2022)

ELEVATION OF NT-PROBNP LEVEL IS ASSOCIATED WITH HIGHER IN-HOSPITAL MORTALITY FOR COVID-19 IN ETHNIC MINORITY COMMUNITY
por: Jadhav, Preeti, et al.
Publicado: (2021)

PROGNOSTIC VALUE OF ELEVATED HIGH-SENSITIVITY TROPONIN LEVEL IN COVID-19 ASSOCIATED HOSPITALIZATIONS IN THE SOUTH BRONX
por: Yue, Bing, et al.
Publicado: (2021)

COMPARISON OF PROGNOSTIC SIGNIFICANCE OF TROPONIN I ELEVATION TO OTHER BIOMARKERS IN PATIENTS HOSPITALIZED WITH COVID 19 INFECTION
por: Jayanna, Manju Bengaluru, et al.
Publicado: (2021)

HIGH-SENSITIVITY CARDIAC TROPONIN T FOR THE DETECTION OF MYOCARDIAL INJURY AND RISK STRATIFICATION IN COVID-19
por: De Michieli, Laura, et al.
Publicado: (2021)

ELEVATED INTERLEUKIN-6 LEVELS IN COVID-19-INFECTED PATIENTS ARE ASSOCIATED WITH MAJOR ADVERSE CARDIAC EVENTS AND/OR MORTALITY
por: Nguyen, Nicholas, et al.
Publicado: (2021)

TROPONIN ELEVATION AS A PREDICTOR FOR OUTCOMES OF PATIENTS DIAGNOSED WITH COVID 19 INFECTION IN A LARGE PUBLIC HOSPITAL IN THE CHICAGO AREA
por: Quelal, Karol, et al.
Publicado: (2021)

CORONARY ARTERY CALCIFICATIONS IN COVID-19 SURVIVORS: ASSOCIATION WITH MYOCARDIAL INJURY AND FUNCTION AFTER 6 WEEKS
por: Groen, R.A., et al.
Publicado: (2022)

Lysophospholipids as Predictive Markers of ST-Elevation Myocardial Infarction (STEMI) and Non-ST-Elevation Myocardial Infarction (NSTEMI)
por: Chorell, Elin, et al.
Publicado: (2020)

RELATIONSHIPS BETWEEN MYOCARDIAL INJURY, INDEX HOSPITALIZATION CHARACTERISTICS, AND LONGER-TERM OUTCOMES IN SARS-COV-2 INFECTION
por: Weber, Brittany, et al.
Publicado: (2021)

THE OCCURRENCE AND MORTALITY ASSOCIATED WITH MYOCARDIAL ISCHEMIA AND INJURY IN SARS-COV-2 INDUCED SEPSIS: A RETROSPECTIVE MULTICENTER OBSERVATIONAL ANALYSIS
por: Solsi, Anup, et al.
Publicado: (2022)

SURVIVAL OUTCOMES OF PEDIATRIC PATIENTS WITH COVID-19 INFECTION AND IN-HOSPITAL CARDIOPULMONARY RESUSCITATION
por: El-Zein, Rayan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8p3aka5lqkd4bd3fj9ecev3icm